Prognostic value of CD34 expression status in patients with myxofibrosarcomas and undifferentiated pleomorphic sarcomas

It is controversial whether patients with myxofibrosarcomas (MFSs) have better prognoses than those with undifferentiated pleomorphic sarcomas (UPSs). No useful prognostic factors have been established to date. We therefore aimed to evaluate the prognostic value of CD34 expression status in 192 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiura, Yoshiya, Machinami, Rikuo, Matsumoto, Seiichi, Kanda, Hiroaki, Ae, Keisuke, Takazawa, Yutaka, Takeuchi, Kengo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322140/
https://www.ncbi.nlm.nih.gov/pubmed/34326362
http://dx.doi.org/10.1038/s41598-021-94834-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322140/
https://www.ncbi.nlm.nih.gov/pubmed/34326362
http://dx.doi.org/10.1038/s41598-021-94834-w

Ejemplares similares